Clinical study of intravenous thrombolysis in acute cerebral infarction

Abstract

Objective To explore the acute cerebral infarction (ACI) super early evolution rule of syndrome and its influencing factors, and provide the basis for cooperation of Chinese and western medicine treatment. Methods 60 patients with acute cerebral infarction in accordance with the digital table method were randomly divided into two groups, control group 30 cases to conventional medical treatment; Based on the observation group had 30 cases in the control group given the original recombinant tissue fibrinolytic enzyme activators (recombinant tissue plasminogen activator, rt-PA) intravenous thrombolysis treatment, and compare the clinical effect of two groups. Results from treatment group patients after 1, 3, 5, 7, 14 d NIHSS were significantly lower than the control group, two groups compared with statistical (P 0.05), the observation group in the wind, phlegm syndrome and exhausted curative effect is better than that of control group, with statistical significance(P 0.05). Conclusion this research can effectively judge the ACI patients with symptoms after intravenous thrombolysis evolution law, by means of combining traditional Chinese and western medicine, targeted prevention and treatment. Improve the clinical curative effect, helps to reduce acute mortality and morbidity, has wide practical value and social benefits, popularization and application can create huge economic benefits. Key words: Brain infarction; Super early; Intravenous thrombolysis; Syndrome